Ginkgo Bioworks is a company that develops a cell programming platform for various end markets. The platform allows the biological production of novel therapeutics, food ingredients, and chemicals. Founded in 2008, the company is based in Boston, Massachusetts, and has a partnership with Selecta Biosciences, Inc. to develop its ImmTOR technology platform.